#immunogenicity — Friday, August 07, 2026 (2 items)
| 0 | ℹ |
The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
(nature.com)
|
Nature Communications 2026-08-07 | #vaccination #clinical trial #immunogenicity #herpesvirus #efficacy | |
| 0 | ℹ |
ZPY-CpG-Ch, a broad coverage vaccine against Streptococcus pneumoniae.
(science.org)
|
Science Advances 2026-08-07 | #vaccination #pneumococcal #immunogenicity #serotype #adjuvant |